The Defense Threat Reduction Agency (DTRA) has awarded Systems Planning and Analysis (SPA), Inc. a $185 million prime contract for Research, Development, Test and Evaluation Subject Matter Expertise Advisory and Assistance Support. SPA's responsibilities in support of the Research and
Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.
Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device
The Department of Defense has awarded three teams, BWX Technologies, Inc., Lynchburg, Virginia; Westinghouse Government Services, Washington, D.C.; and X-energy, LLC, Greenbelt, Maryland; contracts to each begin design work on a mobile nuclear reactor prototype under a Strategic Capabilities
Block MEMS, LLC (Block) has been selected for Phase III of an Intelligence Advanced Research Projects Activity (IARPA) program for the standoff detection of trace and bulk quantities of drugs such as fentanyl, explosives, chemical warfare agents (CWAs) and toxic chemicals. Block is the only
Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases
The U.S. Department of Health and Human Services (HHS) will support tests of organ-on-a-chip technology to determine how it can be used to understand injuries caused by inhaled chlorine gas, a potential national security threat, and to develop treatments for those injuries.
The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,
Researchers from The University of Manchester are developing chemical sensors that can be mounted on to ‘worm robots’, as part of a project involving partners in four European countries to improve detection of people trapped under debris after a disaster.
Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea.
Pluristem Therapeutics Inc. a leading regenerative medicine company developing novel placenta-based cell therapy products is presenting positive results from a series of studies of the company’s PLX-R18 cell therapy product
Zhilong Yang, an assistant professor in the Division of Biology, is the principal investigator on a new, nearly $1.9 million grant from the National Institutes of Health. The five-year project will study how vaccinia virus — a member of the poxvirus family — produces its proteins. This award is
Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement.
Inovio Pharmaceuticals, Inc.has announced that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical CBRN Defense Consortium will provide $8.14 million to support Inovio in
Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts
The poxvirus — with its applications for the investigation of disease development, cross-species infection-caused diseases, vaccine development and cancer virotherapy — is the focus of research by Jia Liu, Ph.D., who has received a $1.86 million grant from the National Institutes of Health to
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), along with Uniformed Services University of the Health Sciences (USU), Profectus Biosciences, Inc., the Vanderbilt University Medical Center, Mapp Biopharmaceutical, Inc., and
DARPA aims to apply the power of social networks to research and development via a novel social media platform purpose-built to quicken the pace of U.S. technology development. Polyplexus, which was recently launched as a public platform, is designed to increase access to scientific